Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:08 PM
Ignite Modification Date:
2025-12-24 @ 2:08 PM
NCT ID:
NCT03122795
Eligibility Criteria:
Inclusion criteria (patient)
* 2 nasal symptoms: 1 of which must be nasal obstruction or discoloured discharge.
* Sinusitis verified by endoscopy or CT-scan.
* Duration \> 12 weeks.
* Previous surgery with patent ostia to the diseased sinuses.
* Signed informed consent to participate in the study.
Inclusion criteria (donor)
* No history of sinonasal or lower airway disease within the last 2 years other than the common cold.
* Accepted as a donor by the patient.
* Signed informed consent to participate in the study.
Exclusion criteria (patient)
* Nasal polyposis.
* Antibiotic treatment within the last 4 weeks.
* On-going or recent participation in another clinical trial.
* Any medication that may affect the results in an unpredictable manner.
* Immune deficiency.
* Allergy to amoxicillin or clavulanate potassium and clarithromycin.
* Pregnancy or breastfeeding.
Exclusion criteria (donor)
* Chronic rhinosinusitis.
* Acute rhinosinusitis within the last two years.
* Nasal polyposis.
* Asthma.
* Antibiotic treatment within the last 4 weeks.
* On-going or recent participation in another clinical trial.
* Clinical findings of sinonasal disease at the inclusion visit.
* Findings in the pre-study pathogen scan that makes the donor unsuitable.
* Pregnancy or breastfeeding.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03122795
Study Brief:
Protocol Section:
NCT03122795